Ye Weiguo's Form 4 filing
Gyre Therapeutics, Inc. (GYRE) · filed May 27, 2026
- Accession no.
- 0001140361-26-022980
- Filed
- May 27, 2026
- Trade date
- May 22-26, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $45.7K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ye WeiguoCIK 0001985496 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 22, 2026 | Common Stock | MOption exerciseAcquired | +3,500 | $0.75 | +$2,625 | 703,500 | Direct | |
| May 22, 2026 | Common Stock | SSaleDisposed | −3,500 | $6.08 | −$21,280 | 700,000 | Direct | |
| May 26, 2026 | Common Stock | MOption exerciseAcquired | +4,000 | $0.75 | +$3,000 | 704,000 | Direct | |
| May 26, 2026 | Common Stock | SSaleDisposed | −4,000 | $6.10 | −$24,400 | 700,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 22, 2026 | Common Stock | MOption exerciseDisposed | −3,500 | $0.00 | $0 | 901,395 | Direct | |
| May 26, 2026 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 897,395 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.